2015 - 2018 The development of epicutaneous allergen-specific immunotherapy for inducing food allergy resistance and the immunological analysis of it's response mechanisms
2016 - 2017 難治性固形がんに対する腫瘍血管傷害性CAR-T細胞療法の開発
2015 - 2016 日本発世界初の次世代マイクロニードルワクチンの量産技術の確立
2014 - 2016 Development of a novel pharmacotherapy using microneedle technology for immunologic skin diseases
2013 - 2016 Analysis of physicochemical characteristics of microneedle patch, and development of novel therapeutic approach for seborrheic keratosis treatment
2012 - 2015 Development of the transcutaneous influenza vaccine formulation using an self-dissolving microneedle patch
Naoki Okada. Development of patch-type vaccination and immunotherapy applying skin-targeted immune regulation technology. 2019. 68. S152-S159
Naoki Okada. Development of Patch-type Vaccine Applying Transcutaneous Delivery Technology. Pharmaceutical and Medical Device Regulatory Science. 2019. 50. 10. 596-601
VEGFR2-specific CAR T cells show improved tumor infiltration in syngeneic mouse glioma models
(Society for Neuro-Oncology (SNO) 28th Annual Meeting and Education)
Lung inflammation induced by poly(I:C) intranasal administration in mice with renal injury and older mice is exacerbated by myeloid-derived suppressor cells
(JSICR MMCB 2023 Joint Symposium)
2008/07 - Controlled Release Society The 2008 CRS Jorge Heller Journal of Controlled Release Outstanding Paper Award A strategy for efficient cross-presentation of CTL-epitope peptides leading to enhanced induction of in vivo tumor immunity
The Japanese Society for Vaccinology
, The Academy of Pharmaceutical Science and Technology, Japan
, Japan Society of Drug Delivery System
, The Japanese Society for Immunology
, Japanese Cancer Association
, The Pharmaceutical Society of Japan